Thursday - January 29, 2026

Category Archives: Professional Services

CinDome Pharma “CIN-102” Market size expansion of Several Folds by 2034

Explore DelveInsight’s comprehensive report on CIN-102 (CinDome Pharma), offering market insights, sales forecast, and analysis through 2034.   [Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on CIN-102 (CinDome Pharma) providing … Continue reading →

Sergio Pineda, Vice President at Blue Group Capital, Helps Businesses Across the U.S. and Canada Navigate Today’s Financing Challenges

Sergio Pineda, Vice President at Blue Group Capital, works with U.S. and Canadian businesses to structure flexible financing solutions. Sergio Pineda, Vice President of Lending at Blue Group Capital, continues to help U.S. and Canadian businesses access flexible financing solutions. … Continue reading →

TRYPTYR by Aerie Pharmaceuticals expected to drive market size of Dry Eye Disease

Explore DelveInsight’s comprehensive report on TRYPTYR (Aerie Pharmaceuticals), offering market insights, sales forecasts, and analysis of the drug landscape through 2034.   [Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on … Continue reading →

Donanemab by Eli Lilly and Company expected to drive market size of Alzheimer’s Disease

Explore the comprehensive Donanemab market report by a leading healthcare research firm, offering detailed insights, sales forecasts, and market analysis up to 2034.   [Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth … Continue reading →

Spinal Cord Injury Market: Growth Momentum Across 7MM to 2034 – DelveInsight | Kringle Pharma, Neuroplast, Abbvie, Mitsubishi Tanabe Pharma, Lineage Cell Therapeutics, NervGen Pharma

The Key Spinal Cord Injury Companies in the market include – Athersys, Olatec Therapeutics, AlaMab therapeutics, ReNetX Bio, Histocell, Lineage Cell Therapeutics, AbbVie, Mitsubishi Tanabe Pharma, Pharmazz, Eusol Biotech, Kringle Pharma, NervGen Pharma, StemCyte, Inc., and others.   DelveInsight’s “Spinal … Continue reading →

Artificial Intelligence in Drug Commercialization: Market Projected to Grow at 24.12% CAGR Through 2032 | DelveInsight

Artificial Intelligence (AI) in Drug Commercialization DelveInsight Business Research, a leading pharmaceutical market research and business consulting firm, has released its latest market intelligence report on AI in Drug Commercialization. The report profiles leading companies, including EVERSANA, Lyfegen, Syneos Health, … Continue reading →

AGC Biologics “TTHX-1114” Market size expansion of Several Folds by 2034

Explore DelveInsight’s comprehensive report on TTHX-1114 (AGC Biologics), featuring market landscape, sales forecast, and market size analysis through 2034.   [Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on TTHX-1114 (AGC … Continue reading →

Nonalcoholic Steatohepatitis Market to Evolve Rapidly Over the Next Decade, DelveInsight Observes | Madrigal Pharmaceuticals, Novo Nordisk, 89bio

Nonalcoholic Steatohepatitis Diagnostics Market Insights, Epidemiology, and Market Forecast-2034 The Key Nonalcoholic Steatohepatitis Companies in the market include – Madrigal Pharmaceuticals, Novo Nordisk A/S, 89bio, Inc., Akero Therapeutics, Inc., Galectin Therapeutics, Sagimet Biosciences, Inventiva Pharma, Zydus Therapeutics, Eli Lilly and … Continue reading →